Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
The patient recived first dose of Shingrix in 2021 and not recived second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (the patient received first dose of in 2021). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: The patient recived first dose of Shingrix in 2021 and not recived second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 03-APR-2025 No personal information provided and no other information such as lot number, expiration date, patient's initials were provided. The vaccine administration facility was the same as primary reporter. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.